| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/09/2005 | EP1504017A2 Mutant chromophores/fluorophores and methods for making and using the same |
| 02/09/2005 | EP1503785A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 02/09/2005 | EP1399572A4 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants |
| 02/09/2005 | EP1287159A4 Enzymatic treatment of whey proteins for the production of antihypertensive peptides, the resulting products and treatment of hypertension in mammals |
| 02/09/2005 | EP1082875A4 Improved brush block housing for propeller deicing system |
| 02/09/2005 | EP1051427A4 Spoil protein and nucleic acid molecules and uses therefor |
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | EP0383799B2 Adheson variants |
| 02/09/2005 | CN1578838A Method and means for producing protein with prospective post-translation modification |
| 02/09/2005 | CN1578836A Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 02/09/2005 | CN1578832A Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
| 02/09/2005 | CN1578678A Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/09/2005 | CN1578673A Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
| 02/09/2005 | CN1576369A Prawn leukasmus rhabdovirus dUTPase gene and coded polypeptide thereof |
| 02/09/2005 | CN1576368A Prawn leukasmus rhabdovirus VP26 gene correlated with infection and coded polypeptide thereof |
| 02/09/2005 | CN1576367A Prawn leukasmus rhabdovirus WP486 gene and coded polypeptide thereof |
| 02/09/2005 | CN1188528C Intercellular adhesion molecule-3 and its binding ligands |
| 02/09/2005 | CN1188519C Fusion proteins comprising HIV-1 Tat and /or Nef proteins |
| 02/09/2005 | CN1188427C Recombinant chimeric peptide antigen for detecting HCMV antibody and production method thereof |
| 02/09/2005 | CN1188172C G-CSF conjugates |
| 02/08/2005 | US6852848 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 02/08/2005 | US6852846 Viral amplification of recombinant messenger RNA in transgenic plants |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
| 02/08/2005 | US6852837 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 02/08/2005 | US6852836 Gene encoding brain-specific membrane protein |
| 02/08/2005 | US6852834 Fusion peptides isolatable by phase transition |
| 02/08/2005 | US6852704 Compositions and methods for reverse gene therapy, wherein a gene therapy vector encoding a gene product (e.g. a protein) which is usually only expressed in cells of an abnormal tissue is delivered to a cell of an animal afflicted with a disease |
| 02/08/2005 | US6852520 DSP-2 dual-specificity phosphatase |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852513 Solid phase synthesis; catalysis without secondary reactions |
| 02/08/2005 | US6852512 Expression vectors for production of foreign proteins as soluble forms |
| 02/08/2005 | US6852511 Heat-inducible promoter |
| 02/08/2005 | US6852510 Host cells containing multiple integrating vectors |
| 02/08/2005 | US6852509 Anti-P53 single-chain antibody fragments and their uses |
| 02/08/2005 | US6852498 Screening efficiency of microbiocides at preventing oomycete infections; obtain sample containing oomycetes, incubate with microbiocide, monitor oomycete response to microbiocide |
| 02/08/2005 | US6852497 Fusion protein |
| 02/08/2005 | US6852486 Detection of leukocyte antigen in sample; obtain cell sample, incubate with bindng protein, detect bound protein, presence of bound protein indicates leukocyte antigen presence |
| 02/08/2005 | US6852322 Surface proteins of Leptospira |
| 02/08/2005 | US6852320 T cell inhibitory receptor compositions and uses thereof |
| 02/08/2005 | CA2278588C Method for increasing the growth of plant cell cultures |
| 02/08/2005 | CA2184183C Inhibin compositions and methods of use thereof |
| 02/08/2005 | CA2180103C Gene encoding adseverin |
| 02/08/2005 | CA2150928C Expression system for producing apolipoprotein ai-m |
| 02/08/2005 | CA2116914C Novel plasmid for production of crm protein and diphtheria toxin |
| 02/08/2005 | CA2110933C Kainate-binding, human cns receptors of the eaa3 family |
| 02/03/2005 | WO2005010196A1 Method for producing dipeptides |
| 02/03/2005 | WO2005010195A1 Method of synthesizing amino-acid-selectively labeled protein |
| 02/03/2005 | WO2005010170A2 Fermentation medium based on a highly hydrolized protein substrate |
| 02/03/2005 | WO2005010165A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/03/2005 | WO2005010155A2 Methods of decoupling reaction scale and protein synthesis yield in batch mode |
| 02/03/2005 | WO2005009369A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/03/2005 | WO2004099408A8 Novel protein and dna coding for the same |
| 02/03/2005 | WO2004050849A3 Recombinant immunotoxin and use in treating tumors |
| 02/03/2005 | WO2004031722A3 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr) |
| 02/03/2005 | WO2003094859A3 Epha2 monoclonal antibodies and methods of use thereof |
| 02/03/2005 | WO2003066665A3 Proteolytic fermenter |
| 02/03/2005 | WO2003064606A3 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 02/03/2005 | WO2001048228A8 Methods and materials relating to gene expression |
| 02/03/2005 | WO2001025401A3 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 02/03/2005 | US20050027115 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027113 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/03/2005 | US20050027109 Preparing genetically engineered therapeutic protein fusion comprised of antibody constant region for use in treatment of metabolic disorders |
| 02/03/2005 | US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 02/03/2005 | US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders |
| 02/03/2005 | US20050026854 Antibody is used to prevent, or treat of graft versus host disease; Antibody dependent cellular cytotoxicity; anti-sense nucleic acid; graft-versus-tumor activity and immunotherapy |
| 02/03/2005 | US20050026837 Novel proteins and methods for producing the proteins |
| 02/03/2005 | US20050026834 Methods for making proteins containing free cysteine residues |
| 02/03/2005 | US20050026278 RNA interference mediating small RNA molecules |
| 02/03/2005 | US20050026269 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants |
| 02/03/2005 | US20050026264 An Asparagine106-glycosylated chicken cystatin having Isoleucine-108 replaced by Threonine-108 has improved freeze resistance as well as improved heat resistance; nonbiodegradable; nonsoftening gel; food processing of surmi comprising preferably nemipterid, mackerel or cod |
| 02/03/2005 | US20050026246 Method for generating diversity |
| 02/03/2005 | US20050026243 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders |
| 02/03/2005 | US20050026232 Monoclonal antibody which preferentially binds leukocyte common antigen-related molecule phosphatase (LAR) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/03/2005 | US20050026226 Serum Paraoxonase |
| 02/03/2005 | US20050026191 Nucleotide sequences coding interferon-inducible proteins in fibroblasts for use in diagnosis, prevention and treatment of cell proliferative, nervous system, glandular and inflammatory diseases |
| 02/03/2005 | US20050026182 Human CDNAS and proteins and uses thereof |
| 02/03/2005 | US20050025775 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material |
| 02/03/2005 | US20050025772 Monoclonal antibody 108-394 binds to shared epitope of protein p24 and protein p26; diagnostic kits; conjugate of antibody attached to a signal generating compound; sensitivity |
| 02/03/2005 | US20050025766 Inducing cytolysis of undesirable cells or immunostimulation by administering a targeting agent for the PML protein or an agent inducing overexpression of the PML protein |
| 02/03/2005 | CA2850891A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 02/03/2005 | CA2532430A1 Humanized versions of monoclonal antibody ds6 that bind tumour antigen ca6 |
| 02/03/2005 | CA2532370A1 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/03/2005 | CA2532035A1 Fugetactic proteins, compositions and methods of use |
| 02/03/2005 | CA2530284A1 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 02/03/2005 | CA2526814A1 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 02/02/2005 | EP1502952A2 Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
| 02/02/2005 | EP1502920A2 Cell surface molecule mediating cell adhesion and signal transmission |
| 02/02/2005 | EP1502603A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM Fc gamma RIIIa POLYMORPHISM |
| 02/02/2005 | EP1502110A2 Qm-7 and qt-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 02/02/2005 | EP1501942A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 02/02/2005 | EP1501936A2 Cytokine protein family |
| 02/02/2005 | EP1501935A2 Low-cost production of peptides |
| 02/02/2005 | EP1501870A2 Rsv proteins, antibodies, compositions, methods and uses |
| 02/02/2005 | EP1501866A2 Apo-2 ligand variants and uses thereof |
| 02/02/2005 | EP1501864A1 Metallo proteinase inhibitory agent |
| 02/02/2005 | EP1501857A2 Novel pancortin-pablo protein interactions and methods of use thereof |
| 02/02/2005 | EP1501855A2 Novel compositions and methods in cancer |
| 02/02/2005 | EP1501544A2 Alcam and alcam modulators |